Robert Welch, MD
Retina Specialist · Provo, UTNPI 1376981894
Payments from drug & device makers
What this record shows
6 manufacturers reported payments, led by US Retina LLC at 57.0% of the total. Reporting peaked in 2022 at $243 and has fallen 61.7% since, to $93 in 2025. That places this record below the midpoint for retina specialist clinicians in UT, where the typical reported total is $2,710.
Across 13 payments — averaging $64.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- US Retina LLC$479
- Genentech USA, Inc.$252
- AbbVie$44
- Regeneron Healthcare Solutions, Inc.$32
- Regeneron$17
- Eyepoint US, Inc.$16
What the payments were for
- Food & beverage$36143%
- Ownership interest$47957%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| US Retina LLC | 4 | $479 |
| Genentech USA, Inc. | 4 | $252 |
| AbbVie | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Regeneron | 1 | $17 |
| Eyepoint US, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lucentis$127
How this compares
$840 in reported general payments places this provider in the 30th percentile of 20 retina specialist providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 189 | $9,272 |
| Atropine Sulfate | 80 | $2,456 |
| Bromfenac Sodium | 14 | $1,894 |
| Ketorolac Tromethamine | 47 | $1,027 |
| Ofloxacin | 86 | $1,008 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 72 | $992 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 17 | $330 |
| Brimonidine Tartrate | 22 | $183 |
| Timolol Maleate | 17 | $177 |
| Latanoprost | 27 | $162 |
| ErythromycinErythromycin Base | 11 | $132 |
| Dorzolamide Hcl | 11 | $120 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Provo
- Jonathan GuntherProvo$632
- Ryan IsomProvo$403
- Jack StringhamProvo$331
- Richard CoreyProvo$147
- Robert KwunSalt Lake City$334K
- Mitchell GoffSalt Lake City$165K
- James HowardSalt Lake City$14K
- David FaberSalt Lake City$10K
- Rebekah GensureSalt Lake City$5K
- Andrew DavisWest Jordan$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.